About
Basic Data Updated:
14 days agoSupreem Pharmaceuticals Mysore Private Limited has been involved in the manufacturing of a wide range of bulk stabilized vitamins, tasteless minerals, and nutraceuticals. These products are carefully crafted and produced at three different locations, including a pharma plant in Nanjangudu, Karnataka, a herbal unit in Mysore, Karnataka, and a pharma unit in Kathmandu, Nepal. With a strong presence across India, the company also exports its products to various countries such as Europe, United States, Taiwan, Singapore, Malaysia, Indonesia, Nepal, Bangladesh, and Pakistan. The company's esteemed clientele includes renowned names in the pharmaceutical industry such as Dr Reddy Labs, Ranbaxy Labs, Nicholas Piramal, Cadila Pharmaceuticals, Cipla Ltd, Glaxo Smith Kline, Merck India, Sandoz, Meyer Organics, Apex Labs, and Wyeth. These partnerships are a testament to the company's commitment to providing high-quality and reliable products to its customers. Supreem Pharmaceuticals Mysore Private Limited takes great pride in its state-of-the-art facilities and advanced technology, which enable the production of superior products.
Industry
Company Details
- Location
Mysore, Karnataka, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24231KA1996PTC020988 |
| Company No. | 020988 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 16 Aug 1996 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Bangalore |
Products or Services related to Supreem Pharmaceuticals Mysore Private Limited
Antacid Drugs
VTM Kit Raw Materials
Herbal Extracts
Vitamin D3 Drops
Financials of Supreem Pharmaceuticals Mysore Private Limited
Supreem Pharmaceuticals Mysore Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 40.44% increase. The company also saw a substantial improvement in profitability, with a 115.25% increase in profit. The company's net worth Soared by an impressive increase of 34.6%.
Corporate Structure
Unlock access to Supreem Pharmaceuticals Mysore's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Supreem Pharmaceuticals Mysore Private Limited
Unlock and access historical data on people associated with Supreem Pharmaceuticals Mysore, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
SR
Sadanand Rao
Managing DirectorAppointment Date: 16-Aug-1996
Status: Current
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 11 Jul 2023 | ₹9.04 Cr | Open |
Karnataka State Financial Corporation Creation Date: 09 Oct 2013 | ₹8.30 Cr | Open |
State Bank Of India Creation Date: 21 Nov 2007 | ₹29.65 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supreem Pharmaceuticals Mysore, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supreem Pharmaceuticals Mysore's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Recent activity within the organization
Annual General Meeting
Supreem Pharmaceuticals Mysore Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Charges
A charge with Axis Bank Limited of Rs. 9.04 cr registered on 11 Jul 2023 with Charge ID 100788923 was modified on 04 Sep 2023.
04 Sep 2023Charges
A charge with Axis Bank Limited amounted to Rs. 9.04 cr with Charge ID 100788923 was registered on 11 Jul 2023.
11 Jul 2023Balance Sheet
Supreem Pharmaceuticals Mysore Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
31 Mar 2023Charges
A charge with State Bank Of India of Rs. 29.65 cr registered on 21 Nov 2007 with Charge ID 10081897 was modified on 04 Jan 2023.
04 Jan 2023
Frequently asked questions
What is the Incorporation or founding date of Supreem Pharmaceuticals Mysore Private Limited?
